Cleared Traditional

K183521 - CNAP Monitor

K183521 is an FDA 510(k) clearance for CNAP Monitor, manufactured by Cnsystems Medizintechnik GmbH. The device is a Class 2 Cardiovascular device with product code DXN cleared through the Traditional 510(k) pathway after a 266-day FDA review.

K183521 · Cnsystems Medizintechnik GmbH · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2019
Decision
266d
Days
Class 2
Risk

K183521 is an FDA 510(k) clearance for the CNAP Monitor. Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Cnsystems Medizintechnik GmbH (Graz, AT). The FDA issued a Cleared decision on September 11, 2019 after a review of 266 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Cnsystems Medizintechnik GmbH devices

FDA 510(k) Submission Details - K183521

510(k) Number K183521 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 19, 2018
Decision Date September 11, 2019
Days to Decision 266 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
141d slower than avg
Panel avg: 125d · This submission: 266d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DXN Device Classification - Class 2, Special Controls

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 568
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K183521.
Arm Blood Pressure Monitor
K192023 · Truly Instrument Limited · Dec 2019
Upper Arm Blood Pressure Monitor
K191673 · Famidoc Technology Company Limited · Nov 2019
Full Automatic (NIBP) Blood Pressure Monitor
K190507 · Health & Life Co., Ltd. · Sep 2019
EV1000 Clinical Platform NI, EV1000 Clinical Platform
K192058 · Edwards Lifesciences, LLC · Aug 2019
Electronic Blood Pressure Monitor
K191180 · Shenzhen AOJ Medical Technology Co., Ltd. · Aug 2019
Blood Pressure Monitor
K190207 · Shenzhen Viatom Technology Co., Ltd. · Aug 2019